Palisade Bio (NASDAQ:PALI) reported quarterly losses of $(0.08) per share. This is a 119.05 percent decrease over earnings of $0.42 per share from the same period last year.
Truist Securities Initiates Coverage On Biote with Buy Rating, Announces Price Target of $10
Truist Securities analyst Gregory Fraser initiates coverage on Biote (NASDAQ:BTMD) with a Buy rating and announces Price Target of $10.